Dismiss Notice
How Does This Work?

You create a free account and set a Gmail filter to forward your Ingress email damage reports.

The damage reports are processed in realtime into the Outgress analytics and alerting engine.

That's the short version.

Is This Allowed?

We believe so, but you decide.

But My Secret Data!

No one on the opposing faction cares who on their team is attacking you. Do you care who on your team is attacking opposing portals?

「明日の医学と医療を拓く」平野智子作 The University of Tokyo 

7 Chome-3 Hongō, Bunkyō-ku, Tōkyō-to 113-0033, Japan

** Some agent names blurred until you log in.
8lQ1zSyFvX
Apr 16, 2025
0FWC6N
Apr 8, 2025
Mar 13, 2025
Rq3AHWxH3
Mar 10, 2025
eZ4PvvK11
Feb 19, 2025
uG8gdta
Feb 16, 2025
QlJozbR
Feb 12, 2025
3ZE6Ne1
Jan 29, 2025
SVPxQjY
Jan 24, 2025
9CSXeNuhvm
Jan 3, 2025
ivcjJwc
Dec 23, 2024
AiaEyH9
Dec 17, 2024
Dec 13, 2024
OxQaRED
Nov 27, 2024
MMLAXGu
Nov 19, 2024
l200cYS
Nov 14, 2024
RPL3zAe
Nov 14, 2024
This is not exhaustive information about the portal, 「明日の医学と医療を拓く」平野智子作 The University of Tokyo. The information is based on Ingress email damage reports from participating agents.
Sunday
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
12 AM
 
 
 
 
 
 
 
1 AM
 
 
 
 
 
 
 
2 AM
 
 
 
 
 
 
 
3 AM
 
 
 
 
 
 
 
4 AM
 
 
 
 
 
 
 
5 AM
 
 
 
 
 
 
 
6 AM
 
 
 
 
 
 
 
7 AM
 
 
 
 
 
 
 
8 AM
 
 
 
 
 
 
 
9 AM
 
 
 
 
 
 
 
10 AM
 
 
 
 
 
 
 
11 AM
 
 
 
 
 
 
 
12 PM
 
 
 
 
 
 
 
1 PM
 
 
 
 
 
 
 
2 PM
 
 
 
 
 
 
 
3 PM
 
 
 
 
 
 
 
4 PM
 
 
 
 
 
 
 
5 PM
 
 
 
 
 
 
 
6 PM
 
 
 
 
 
 
 
7 PM
 
 
 
 
 
 
 
8 PM
 
 
 
 
 
 
 
9 PM
 
 
 
 
 
 
 
10 PM
 
 
 
 
 
 
 
11 PM
 
 
 
 
 
 
 
    Agents who have owned this portal:
  1. clareza
  2. hayanyan
  3. i196
  4. moe4l6
  5. synnakano
  6. ts0ma
  7. youril
You must be logged in to see the notes for this portal.
You must be logged in to view who has keys for this portal.
You must be logged in to view who has claimed this portal.
The ability to manage agents in your area of play is a feature reserved for "Commander" premium users.